Global and Japan Hyperimmune Serum Market Insights, Forecast to 2027
SKU ID : QYR-19222390 | Publishing Date : 24-Sep-2021 | No. of pages : 148
Detailed TOC of Global and Japan Hyperimmune Serum Market Insights, Forecast to 2027
1 Study Coverage1.1 Hyperimmune Serum Product Introduction
1.2 Market by Type
1.2.1 Global Hyperimmune Serum Market Size Growth Rate by Type
1.2.2 Hepatitis B Immunoglobulins
1.2.3 Rabies Immunoglobulins
1.2.4 Tetanus Immunoglobulins
1.2.5 Rho(D) Immunoglobulins
1.2.6 Other
1.3 Market by Application
1.3.1 Global Hyperimmune Serum Market Size Growth Rate by Application
1.3.2 Government Institutions
1.3.3 Private Sector
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hyperimmune Serum Market Size, Estimates and Forecasts
2.1.1 Global Hyperimmune Serum Revenue 2016-2027
2.1.2 Global Hyperimmune Serum Sales 2016-2027
2.2 Global Hyperimmune Serum, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Hyperimmune Serum Historical Market Size by Region (2016-2021)
2.3.1 Global Hyperimmune Serum Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Hyperimmune Serum Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Hyperimmune Serum Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Hyperimmune Serum Sales Forecast by Region (2022-2027)
2.4.2 Global Hyperimmune Serum Revenue Forecast by Region (2022-2027)
3 Global Hyperimmune Serum Competitor Landscape by Players
3.1 Global Top Hyperimmune Serum Manufacturers by Sales
3.1.1 Global Hyperimmune Serum Sales by Manufacturer (2016-2021)
3.1.2 Global Hyperimmune Serum Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Hyperimmune Serum Manufacturers by Revenue
3.2.1 Key Hyperimmune Serum Manufacturers Covered: Ranking by Revenue
3.2.2 Global Hyperimmune Serum Revenue by Manufacturers (2016-2021)
3.2.3 Global Hyperimmune Serum Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Hyperimmune Serum Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Hyperimmune Serum Revenue in 2020
3.2.6 Global Hyperimmune Serum Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Hyperimmune Serum Price by Manufacturers
3.4 Global Hyperimmune Serum Manufacturing Base Distribution, Product Types
3.4.1 Hyperimmune Serum Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hyperimmune Serum Product Type
3.4.3 Date of International Manufacturers Enter into Hyperimmune Serum Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Hyperimmune Serum Market Size by Type (2016-2021)
4.1.1 Global Hyperimmune Serum Sales by Type (2016-2021)
4.1.2 Global Hyperimmune Serum Revenue by Type (2016-2021)
4.1.3 Hyperimmune Serum Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Hyperimmune Serum Market Size Forecast by Type (2022-2027)
4.2.1 Global Hyperimmune Serum Sales Forecast by Type (2022-2027)
4.2.2 Global Hyperimmune Serum Revenue Forecast by Type (2022-2027)
4.2.3 Hyperimmune Serum Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Hyperimmune Serum Market Size by Application (2016-2021)
5.1.1 Global Hyperimmune Serum Sales by Application (2016-2021)
5.1.2 Global Hyperimmune Serum Revenue by Application (2016-2021)
5.1.3 Hyperimmune Serum Price by Application (2016-2021)
5.2 Hyperimmune Serum Market Size Forecast by Application (2022-2027)
5.2.1 Global Hyperimmune Serum Sales Forecast by Application (2022-2027)
5.2.2 Global Hyperimmune Serum Revenue Forecast by Application (2022-2027)
5.2.3 Global Hyperimmune Serum Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Hyperimmune Serum Market Size YoY Growth 2016-2027
6.1.1 Japan Hyperimmune Serum Sales YoY Growth 2016-2027
6.1.2 Japan Hyperimmune Serum Revenue YoY Growth 2016-2027
6.1.3 Japan Hyperimmune Serum Market Share in Global Market 2016-2027
6.2 Japan Hyperimmune Serum Market Size by Players (International and Local Players)
6.2.1 Japan Top Hyperimmune Serum Players by Sales (2016-2021)
6.2.2 Japan Top Hyperimmune Serum Players by Revenue (2016-2021)
6.3 Japan Hyperimmune Serum Historic Market Review by Type (2016-2021)
6.3.1 Japan Hyperimmune Serum Sales Market Share by Type (2016-2021)
6.3.2 Japan Hyperimmune Serum Revenue Market Share by Type (2016-2021)
6.3.3 Japan Hyperimmune Serum Price by Type (2016-2021)
6.4 Japan Hyperimmune Serum Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Hyperimmune Serum Sales Forecast by Type (2022-2027)
6.4.2 Japan Hyperimmune Serum Revenue Forecast by Type (2022-2027)
6.4.3 Japan Hyperimmune Serum Price Forecast by Type (2022-2027)
6.5 Japan Hyperimmune Serum Historic Market Review by Application (2016-2021)
6.5.1 Japan Hyperimmune Serum Sales Market Share by Application (2016-2021)
6.5.2 Japan Hyperimmune Serum Revenue Market Share by Application (2016-2021)
6.5.3 Japan Hyperimmune Serum Price by Application (2016-2021)
6.6 Japan Hyperimmune Serum Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Hyperimmune Serum Sales Forecast by Application (2022-2027)
6.6.2 Japan Hyperimmune Serum Revenue Forecast by Application (2022-2027)
6.6.3 Japan Hyperimmune Serum Price Forecast by Application (2022-2027)
7 North America
7.1 North America Hyperimmune Serum Market Size YoY Growth 2016-2027
7.2 North America Hyperimmune Serum Market Facts & Figures by Country
7.2.1 North America Hyperimmune Serum Sales by Country (2016-2021)
7.2.2 North America Hyperimmune Serum Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Hyperimmune Serum Market Size YoY Growth 2016-2027
8.2 Asia Pacific Hyperimmune Serum Market Facts & Figures by Region
8.2.1 Asia Pacific Hyperimmune Serum Sales by Region (2016-2021)
8.2.2 Asia Pacific Hyperimmune Serum Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Hyperimmune Serum Market Size YoY Growth 2016-2027
9.2 Europe Hyperimmune Serum Market Facts & Figures by Country
9.2.1 Europe Hyperimmune Serum Sales by Country (2016-2021)
9.2.2 Europe Hyperimmune Serum Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Hyperimmune Serum Market Size YoY Growth 2016-2027
10.2 Latin America Hyperimmune Serum Market Facts & Figures by Country
10.2.1 Latin America Hyperimmune Serum Sales by Country (2016-2021)
10.2.2 Latin America Hyperimmune Serum Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Hyperimmune Serum Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Hyperimmune Serum Market Facts & Figures by Country
11.2.1 Middle East and Africa Hyperimmune Serum Sales by Country (2016-2021)
11.2.2 Middle East and Africa Hyperimmune Serum Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 CSL Behring
12.1.1 CSL Behring Corporation Information
12.1.2 CSL Behring Description and Business Overview
12.1.3 CSL Behring Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021)
12.1.4 CSL Behring Hyperimmune Serum Products Offered
12.1.5 CSL Behring Recent Development
12.2 Grifols
12.2.1 Grifols Corporation Information
12.2.2 Grifols Description and Business Overview
12.2.3 Grifols Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Grifols Hyperimmune Serum Products Offered
12.2.5 Grifols Recent Development
12.3 Biotest
12.3.1 Biotest Corporation Information
12.3.2 Biotest Description and Business Overview
12.3.3 Biotest Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Biotest Hyperimmune Serum Products Offered
12.3.5 Biotest Recent Development
12.4 Kedrion
12.4.1 Kedrion Corporation Information
12.4.2 Kedrion Description and Business Overview
12.4.3 Kedrion Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Kedrion Hyperimmune Serum Products Offered
12.4.5 Kedrion Recent Development
12.5 CBPO
12.5.1 CBPO Corporation Information
12.5.2 CBPO Description and Business Overview
12.5.3 CBPO Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021)
12.5.4 CBPO Hyperimmune Serum Products Offered
12.5.5 CBPO Recent Development
12.6 Emergent (Cangene)
12.6.1 Emergent (Cangene) Corporation Information
12.6.2 Emergent (Cangene) Description and Business Overview
12.6.3 Emergent (Cangene) Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Emergent (Cangene) Hyperimmune Serum Products Offered
12.6.5 Emergent (Cangene) Recent Development
12.7 Kamada
12.7.1 Kamada Corporation Information
12.7.2 Kamada Description and Business Overview
12.7.3 Kamada Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Kamada Hyperimmune Serum Products Offered
12.7.5 Kamada Recent Development
12.8 CNBG
12.8.1 CNBG Corporation Information
12.8.2 CNBG Description and Business Overview
12.8.3 CNBG Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021)
12.8.4 CNBG Hyperimmune Serum Products Offered
12.8.5 CNBG Recent Development
12.9 Hualan Bio
12.9.1 Hualan Bio Corporation Information
12.9.2 Hualan Bio Description and Business Overview
12.9.3 Hualan Bio Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Hualan Bio Hyperimmune Serum Products Offered
12.9.5 Hualan Bio Recent Development
12.10 Shanghai RAAS
12.10.1 Shanghai RAAS Corporation Information
12.10.2 Shanghai RAAS Description and Business Overview
12.10.3 Shanghai RAAS Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Shanghai RAAS Hyperimmune Serum Products Offered
12.10.5 Shanghai RAAS Recent Development
12.11 CSL Behring
12.11.1 CSL Behring Corporation Information
12.11.2 CSL Behring Description and Business Overview
12.11.3 CSL Behring Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021)
12.11.4 CSL Behring Hyperimmune Serum Products Offered
12.11.5 CSL Behring Recent Development
12.12 ADMA Biologics
12.12.1 ADMA Biologics Corporation Information
12.12.2 ADMA Biologics Description and Business Overview
12.12.3 ADMA Biologics Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021)
12.12.4 ADMA Biologics Products Offered
12.12.5 ADMA Biologics Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Hyperimmune Serum Industry Trends
13.2 Hyperimmune Serum Market Drivers
13.3 Hyperimmune Serum Market Challenges
13.4 Hyperimmune Serum Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hyperimmune Serum Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and Japan Hyperimmune Serum Market Insights, Forecast to 2027
List of TablesTable 1. Global Hyperimmune Serum Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Hepatitis B Immunoglobulins
Table 3. Major Manufacturers of Rabies Immunoglobulins
Table 4. Major Manufacturers of Tetanus Immunoglobulins
Table 5. Major Manufacturers of Rho(D) Immunoglobulins
Table 6. Major Manufacturers of Other
Table 7. Global Hyperimmune Serum Market Size Growth Rate by Application (2021-2027) & (Kiloton)
Table 8. Global Hyperimmune Serum Market Size by Region (Kiloton) & (US$ Million), 2016 VS 2021 VS 2027
Table 9. Global Hyperimmune Serum Sales by Regions (2016-2021) & (Kiloton)
Table 10. Global Hyperimmune Serum Sales Market Share by Regions (2016-2021)
Table 11. Global Hyperimmune Serum Revenue by Regions (2016-2021) & (US$ Million)
Table 12. Global Hyperimmune Serum Sales Forecast by Region (2022-2027) & (Kiloton)
Table 13. Global Hyperimmune Serum Sales Market Share Forecast by Region (2022-2027)
Table 14. Global Hyperimmune Serum Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 15. Global Hyperimmune Serum Revenue Market Share Forecast by Region (2022-2027)
Table 16. Global Hyperimmune Serum Sales by Manufacturers (2016-2021) (Kiloton)
Table 17. Global Hyperimmune Serum Sales Share by Manufacturers (2016-2021)
Table 18. Ranking of Global Top Hyperimmune Serum Manufacturers by Revenue (US$ Million) in 2020
Table 19. Hyperimmune Serum Revenue by Manufacturers (2016-2021) (US$ Million)
Table 20. Hyperimmune Serum Revenue Share by Manufacturers (2016-2021)
Table 21. Global Hyperimmune Serum Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 22. Global Hyperimmune Serum by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hyperimmune Serum as of 2020)
Table 23. Key Manufacturers Hyperimmune Serum Price (2016-2021) (US$/Ton)
Table 24. Hyperimmune Serum Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Hyperimmune Serum Product Type
Table 26. Date of International Manufacturers Enter into Hyperimmune Serum Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Hyperimmune Serum Sales by Type (2016-2021) (Kiloton)
Table 29. Global Hyperimmune Serum Sales Share by Type (2016-2021)
Table 30. Global Hyperimmune Serum Revenue by Type (2016-2021) (US$ Million)
Table 31. Global Hyperimmune Serum Revenue Share by Type (2016-2021)
Table 32. Hyperimmune Serum Average Selling Price (ASP) by Type (2016-2021) & (US$/Ton)
Table 33. Global Hyperimmune Serum Sales Forecast by Type (2022-2027) & (Kiloton)
Table 34. Global Hyperimmune Serum Sales Market Share Forecast by Type (2022-2027)
Table 35. Global Hyperimmune Serum Revenue Forecast V (2022-2027) & (US$ Million)
Table 36. Global Hyperimmune Serum Revenue Market Share Forecast by Type (2022-2027)
Table 37. Global Hyperimmune Serum Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Ton)
Table 38. Global Hyperimmune Serum Sales by Application (2016-2021) (Kiloton)
Table 39. Global Hyperimmune Serum Sales Share by Application (2016-2021)
Table 40. Global Hyperimmune Serum Revenue by Application (2016-2021) (US$ Million)
Table 41. Global Hyperimmune Serum Revenue Share by Application (2016-2021)
Table 42. Hyperimmune Serum Average Selling Price (ASP) by Application (2016-2021) & (US$/Ton)
Table 43. Global Hyperimmune Serum Sales Forecast by Application (2022-2027) & (Kiloton)
Table 44. Global Hyperimmune Serum Sales Market Share Forecast by Application (2022-2027)
Table 45. Global Hyperimmune Serum Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 46. Global Hyperimmune Serum Revenue Market Share Forecast by Application (2022-2027)
Table 47. Global Hyperimmune Serum Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Ton)
Table 48. Japan Hyperimmune Serum Sales (Kiloton) of Key Companies (2016-2021)
Table 49. Japan Hyperimmune Serum Sales Share by Company (2016-2021)
Table 50. Japan Hyperimmune Serum Revenue (US$ Million) by Company (2016-2021)
Table 51. Japan Hyperimmune Serum Revenue Share by Company (2016-2021)
Table 52. Japan Hyperimmune Serum Sales (Kiloton) by Type (2016-2021)
Table 53. Japan Hyperimmune Serum Sales Share by Type (2016-2021)
Table 54. Japan Hyperimmune Serum Revenue (US$ Million) Market Share by Type (2016-2021)
Table 55. Japan Hyperimmune Serum Price (US$/Ton) by Type (2016-2021)
Table 56. Japan Hyperimmune Serum Sales (Kiloton) by Type (2022-2027)
Table 57. Japan Hyperimmune Serum Sales Share by Type (2022-2027)
Table 58. Japan Hyperimmune Serum Revenue (US$ Million) Market Share by Type (2022-2027)
Table 59. Japan Hyperimmune Serum Revenue Share by Type (2022-2027)
Table 60. Japan Hyperimmune Serum Price (US$/Ton) by Type (2022-2027)
Table 61. Japan Hyperimmune Serum Sales (Kiloton) by Application (2016-2021)
Table 62. Japan Hyperimmune Serum Sales Share by Application (2016-2021)
Table 63. Japan Hyperimmune Serum Revenue (US$ Million) Market Share by Application (2016-2021)
Table 64. Japan Hyperimmune Serum Price (US$/Ton) by Application (2016-2021)
Table 65. Japan Hyperimmune Serum Sales (Kiloton) by Application (2022-2027)
Table 66. Japan Hyperimmune Serum Sales Share by Application (2022-2027)
Table 67. Japan Hyperimmune Serum Revenue (US$ Million) Market Share by Application (2022-2027)
Table 68. Japan Hyperimmune Serum Revenue Share by Application (2022-2027)
Table 69. Japan Hyperimmune Serum Price (US$/Ton) by Application (2022-2027)
Table 70. North America Hyperimmune Serum Sales by Country (2016-2021) & (Kiloton)
Table 71. North America Hyperimmune Serum Sales Market Share by Country (2016-2021)
Table 72. North America Hyperimmune Serum Revenue by Country (2016-2021) & (US$ Million)
Table 73. North America Hyperimmune Serum Revenue Market Share by Country (2016-2021)
Table 74. Asia Pacific Hyperimmune Serum Sales by Region (2016-2021) & (Kiloton)
Table 75. Asia Pacific Hyperimmune Serum Sales Market Share by Region (2016-2021)
Table 76. Asia Pacific Hyperimmune Serum Revenue by Region (2016-2021) & (US$ Million)
Table 77. Asia Pacific Hyperimmune Serum Revenue Market Share by Region (2016-2021)
Table 78. Europe Hyperimmune Serum Sales by Country (2016-2021) & (Kiloton)
Table 79. Europe Hyperimmune Serum Sales Market Share by Country (2016-2021)
Table 80. Europe Hyperimmune Serum Revenue by Country (2016-2021) & (US$ Million)
Table 81. Europe Hyperimmune Serum Revenue Market Share by Country (2016-2021)
Table 82. Latin America Hyperimmune Serum Sales by Country (2016-2021) & (Kiloton)
Table 83. Latin America Hyperimmune Serum Sales Market Share by Country (2016-2021)
Table 84. Latin Americaa Hyperimmune Serum Revenue by Country (2016-2021) & (US$ Million)
Table 85. Latin America Hyperimmune Serum Revenue Market Share by Country (2016-2021)
Table 86. Middle East and Africa Hyperimmune Serum Sales by Country (2016-2021) & (Kiloton)
Table 87. Middle East and Africa Hyperimmune Serum Sales Market Share by Country (2016-2021)
Table 88. Middle East and Africa Hyperimmune Serum Revenue by Country (2016-2021) & (US$ Million)
Table 89. Middle East and Africa Hyperimmune Serum Revenue Market Share by Country (2016-2021)
Table 90. CSL Behring Corporation Information
Table 91. CSL Behring Description and Business Overview
Table 92. CSL Behring Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 93. CSL Behring Hyperimmune Serum Product
Table 94. CSL Behring Recent Development
Table 95. Grifols Corporation Information
Table 96. Grifols Description and Business Overview
Table 97. Grifols Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 98. Grifols Product
Table 99. Grifols Recent Development
Table 100. Biotest Corporation Information
Table 101. Biotest Description and Business Overview
Table 102. Biotest Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 103. Biotest Product
Table 104. Biotest Recent Development
Table 105. Kedrion Corporation Information
Table 106. Kedrion Description and Business Overview
Table 107. Kedrion Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 108. Kedrion Product
Table 109. Kedrion Recent Development
Table 110. CBPO Corporation Information
Table 111. CBPO Description and Business Overview
Table 112. CBPO Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 113. CBPO Product
Table 114. CBPO Recent Development
Table 115. Emergent (Cangene) Corporation Information
Table 116. Emergent (Cangene) Description and Business Overview
Table 117. Emergent (Cangene) Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 118. Emergent (Cangene) Product
Table 119. Emergent (Cangene) Recent Development
Table 120. Kamada Corporation Information
Table 121. Kamada Description and Business Overview
Table 122. Kamada Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 123. Kamada Product
Table 124. Kamada Recent Development
Table 125. CNBG Corporation Information
Table 126. CNBG Description and Business Overview
Table 127. CNBG Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 128. CNBG Product
Table 129. CNBG Recent Development
Table 130. Hualan Bio Corporation Information
Table 131. Hualan Bio Description and Business Overview
Table 132. Hualan Bio Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 133. Hualan Bio Product
Table 134. Hualan Bio Recent Development
Table 135. Shanghai RAAS Corporation Information
Table 136. Shanghai RAAS Description and Business Overview
Table 137. Shanghai RAAS Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 138. Shanghai RAAS Product
Table 139. Shanghai RAAS Recent Development
Table 140. Sichuan Yuanda Shuyang Corporation Information
Table 141. Sichuan Yuanda Shuyang Description and Business Overview
Table 142. Sichuan Yuanda Shuyang Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 143. Sichuan Yuanda Shuyang Product
Table 144. Sichuan Yuanda Shuyang Recent Development
Table 145. ADMA Biologics Corporation Information
Table 146. ADMA Biologics Description and Business Overview
Table 147. ADMA Biologics Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 148. ADMA Biologics Product
Table 149. ADMA Biologics Recent Development
Table 150. Hyperimmune Serum Market Trends
Table 151. Hyperimmune Serum Market Drivers
Table 152. Hyperimmune Serum Market Challenges
Table 153. Hyperimmune Serum Market Restraints
Table 154. Hyperimmune Serum Customers List
Table 155. Hyperimmune Serum Distributors List
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Hyperimmune Serum Product Picture
Figure 2. Global Hyperimmune Serum Sales Market Share by Type in 2020 & 2027
Figure 3. Hepatitis B Immunoglobulins Product Picture
Figure 4. Rabies Immunoglobulins Product Picture
Figure 5. Tetanus Immunoglobulins Product Picture
Figure 6. Rho(D) Immunoglobulins Product Picture
Figure 7. Other Product Picture
Figure 8. Global Hyperimmune Serum Sales Market Share by Application in 2020 & 2027
Figure 9. Government Institutions
Figure 10. Private Sector
Figure 11. Other
Figure 12. Hyperimmune Serum Report Years Considered
Figure 13. Global Hyperimmune Serum Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Hyperimmune Serum Market Size 2016-2027 (US$ Million)
Figure 15. Global Hyperimmune Serum Sales 2016-2027 (Kiloton)
Figure 16. Global Hyperimmune Serum Market Size Market Share by Region: 2021 Versus 2027
Figure 17. Global Hyperimmune Serum Sales Market Share by Region (2016-2021)
Figure 18. Global Hyperimmune Serum Sales Market Share by Region in 2020
Figure 19. Global Hyperimmune Serum Revenue Market Share by Region (2016-2021)
Figure 20. Global Hyperimmune Serum Revenue Market Share by Region in 2020
Figure 21. Global Hyperimmune Serum Sales Share by Manufacturer in 2020
Figure 22. The Top 10 and 5 Players Market Share by Hyperimmune Serum Revenue in 2020
Figure 23. Hyperimmune Serum Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 24. Global Hyperimmune Serum Sales Market Share by Type (2016-2021)
Figure 25. Global Hyperimmune Serum Sales Market Share by Type in 2020
Figure 26. Global Hyperimmune Serum Revenue Market Share by Type (2016-2021)
Figure 27. Global Hyperimmune Serum Revenue Market Share by Type in 2020
Figure 28. Global Hyperimmune Serum Sales Market Share by Application (2016-2021)
Figure 29. Global Hyperimmune Serum Sales Market Share by Application in 2020
Figure 30. Global Hyperimmune Serum Revenue Market Share by Application (2016-2021)
Figure 31. Global Hyperimmune Serum Revenue Market Share by Application in 2020
Figure 32. Japan Hyperimmune Serum Sales Growth Rate 2016-2027 (Kiloton)
Figure 33. Japan Hyperimmune Serum Revenue Growth Rate 2016-2027 (US$ Million)
Figure 34. Japan Hyperimmune Serum Market Share in Global Market 2016-2027
Figure 35. Japan 5 and 10 Largest Hyperimmune Serum Players Market Share by Revenue in Hyperimmune Serum in 2020
Figure 36. Japan Hyperimmune Serum Revenue Share by Type (2016-2021)
Figure 37. Japan Hyperimmune Serum Revenue Growth Rate by Type in 2016 & 2020
Figure 38. Japan Hyperimmune Serum Revenue Share by Application (2016-2021)
Figure 39. Japan Hyperimmune Serum Revenue Growth Rate by Application in 2016 & 2020
Figure 40. North America Hyperimmune Serum Sales Growth Rate 2016-2021 (Kiloton)
Figure 41. North America Hyperimmune Serum Revenue Growth Rate 2016-2021 (US$ Million)
Figure 42. North America Hyperimmune Serum Sales Market Share by Country in 2020
Figure 43. North America Hyperimmune Serum Revenue Market Share by Country in 2020
Figure 44. U.S. Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton)
Figure 45. U.S. Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Canada Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton)
Figure 47. Canada Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Europe Hyperimmune Serum Sales Growth Rate 2016-2021 (Kiloton)
Figure 49. Europe Hyperimmune Serum Revenue Growth Rate 2016-2021 (US$ Million)
Figure 50. Europe Hyperimmune Serum Sales Market Share by Country in 2020
Figure 51. Europe Hyperimmune Serum Revenue Market Share by Country in 2020
Figure 52. Germany Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton)
Figure 53. Germany Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. France Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton)
Figure 55. France Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. U.K. Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton)
Figure 57. U.K. Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Italy Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton)
Figure 59. Italy Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Russia Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton)
Figure 61. Russia Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Asia Pacific Hyperimmune Serum Sales Growth Rate 2016-2021 (Kiloton)
Figure 63. Asia Pacific Hyperimmune Serum Revenue Growth Rate 2016-2021 (US$ Million)
Figure 64. Asia Pacific Hyperimmune Serum Sales Market Share by Region in 2020
Figure 65. Asia Pacific Hyperimmune Serum Revenue Market Share by Region in 2020
Figure 66. China Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton)
Figure 67. China Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. Japan Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton)
Figure 69. Japan Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. South Korea Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton)
Figure 71. South Korea Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. India Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton)
Figure 73. India Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Australia Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton)
Figure 75. Australia Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Taiwan Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton)
Figure 77. Taiwan Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Indonesia Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton)
Figure 79. Indonesia Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Thailand Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton)
Figure 81. Thailand Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Malaysia Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton)
Figure 83. Malaysia Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Philippines Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton)
Figure 85. Philippines Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Vietnam Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton)
Figure 87. Vietnam Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Latin America Hyperimmune Serum Sales Growth Rate 2016-2021 (Kiloton)
Figure 89. Latin America Hyperimmune Serum Revenue Growth Rate 2016-2021 (US$ Million)
Figure 90. Latin America Hyperimmune Serum Sales Market Share by Country in 2020
Figure 91. Latin America Hyperimmune Serum Revenue Market Share by Country in 2020
Figure 92. Mexico Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton)
Figure 93. Mexico Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Brazil Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton)
Figure 95. Brazil Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Argentina Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton)
Figure 97. Argentina Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 98. Middle East and Africa Hyperimmune Serum Sales Growth Rate 2016-2021 (Kiloton)
Figure 99. Middle East and Africa Hyperimmune Serum Revenue Growth Rate 2016-2021 (US$ Million)
Figure 100. Middle East and Africa Hyperimmune Serum Sales Market Share by Country in 2020
Figure 101. Middle East and Africa Hyperimmune Serum Revenue Market Share by Country in 2020
Figure 102. Turkey Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton)
Figure 103. Turkey Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. Saudi Arabia Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton)
Figure 105. Saudi Arabia Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. UAE Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton)
Figure 107. UAE Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 108. Hyperimmune Serum Value Chain
Figure 109. Channels of Distribution
Figure 110. Distributors Profiles
Figure 111. Bottom-up and Top-down Approaches for This Report
Figure 112. Data Triangulation
Figure 113. Key Executives Interviewed
Keyplayers in Global and Japan Hyperimmune Serum Market Insights, Forecast to 2027
CSL BehringGrifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics